References
- AMMOURY, N., FESSI, H., DEVISSAGUET, J. P., DUBRASQUET, M. and BENITA, S., 1991, Jejunal absorption, pharmacological activity, and pharmacokinetic evaluation of indomethacin-loaded poly(D,L-lactide) and poly(isobutyl-cyanoacrylate) nanocapsules in rats. Pharmaceutical Research, 8, 101–105.
- ANDRIEU, V., FESSI, H., DUBRASQUET, M., DEVISSAGUET, J. P., PUISIETJX, F. and BENITA, S., 1989, Pharmacokinetic evaluation of indomethacin nanocapsules. Drug Design Delivery, 4, 295–302.
- APRAHAMIAN, M., MICHEL, C., HUMBERT, W., DEVISSAGUET, J. P. and DAMGE, C., 1987, Transmucosal passage of polyalkylcyanoacrylate nanocapsules as a new drug carrier in the small intestine. Biology of the Cell, 61, 69–76.
- BEESON, J. G., WINSTANLEY, P. A., MCFADDEN, G. I. and BROWN, G. V., 2001, New agents to combat malaria. Nature Medicine, 7, 149–150.
- CALVO, P., REMUSTAN-LOPEZ, C., VILA-JATO, J. L. and ALONSO, M. J., 1997, Development of ccpositively charged colloidal drug carriers: chitosan-coated polyester nanocapsules and submicro-emulsions. Colloidal Polymer Sciences, 275, 46–53.
- FESSI, H., PUISIEUX, F., DEVISSAGUET, J. PH., AMMOURY, N. and BENITA, S., 1989, Nanocapsule formation by interfacial polymer deposition following solvent displacement. International Journal of Pharmaceutics, 55, R1–R4.
- HE, P., DAVIS, S. S. and ILLum, L., 1999, Sustained release chitosan microspheres prepared by novel spray-drying methods. Journal of Microencapsulation, 16,343-355. KEENIHAN, S. H., 2001, Triclosan offers new hope for malaria therapy. Trends in Parasitology, 17, 263.
- KIM, J.-C., SONG, M.-E., KIM, M.-J., LEE, E.-J., PARK, S.-K., RANG, M.-J. and AHN, H.-J., 2002, Preparation and characterization of Triclosan-containing vesicles. Colloids and Surfaces B: Biointerfaces, 26, 235–241.
- LEGRAND, P., BARRATT, G., MOSQUEIRA, V., FESSI, H. and DEVISSAGUET, H. P., 1999, Polymeric nanocapsules ad drug delivery systems: a review. STP Pharma Sciences, 9, 411–418.
- LEVY, M. Y. and BENITA, S., 1990, Drug release from submicronized o/w emulsion: a new in vitro kinetic evaluation model. International Journal of Pharmaceutics, 66, 29–37.
- MI, F. L., WONG, T. B. and SHYU, S. S., 1997, Sustained release of oxytetracycline from chitosan microspheres prepared by interfacial acylation and spray hardening methods. Journal of Microencapsulation, 14, 587–591.
- PINON, S. E., GANEM, R. A. and QUINTANAR, G. D., 2002, Recent advances in the development of local drug delivery systems for the treatment of gingivitis and periodontitis, Revista Mexicana de Ciencias Farmaceuticas, 33, 48–57.
- PONCHEL, G., and IRACHE, J., 1998, Specific and non-specific bioadhesive particulate systems for oral delivery to the gastrointestinal tract. Advances in Drug Delivery Reviews, 34, 191–219.
- RIDLEY, R. G., 2002, Medical need, scientific opportunity and the drive for antimalarial drugs. Nature, 415, 686–693.
- SEGUNDO-PINON, E., JACQUES, Y., GANEM-QUINTANAR, A. and QUINTANAR-GUERRERO, D., 2000, Optimization of a process to obtain nanoparticles of triclosan for periodontal treatment. Proceedings of the International Symposium on Controlled Release of Bioactive Materials, Paris, France, July 7th-July 13th, 1138–1139.
- SUGUNA, K., SUROLIA, A. and SUROLIA, N., 2001, Structural basis for triclosan and NAD binding to enoyl-ACP reductase of Plasmodium falciparum. Biochemical and Biophysical Research Communications, 283, 224–228.
- SUROLIA, N. and SUROLIA, A., 2001, Triclosan offers protection against blood stages of smalaria by inhibiting enoyl-ACP reductase of Plasmodium falciparum. Nature Medicine, 7, 167–173.